Eve Holding, focused on developing electric vertical takeoff and landing (eVTOL) aircraft, reported a net loss of $58.1 million in Q3 2026, up from $46.9 million in Q3 2025. The increased loss is mainly due to higher research and development expenses as the company advances its Urban Air Mobility products, including collaboration with Embraer. Despite the losses, Eve maintains strong liquidity with $356 million in cash and equivalents and expects funding to support operations through 2028. The company remains pre-revenue as it focuses on aircraft development and ecosystem building.
Eve Holding, Inc. reports a net loss of $58.1 million in Q3 2026 as key context. For readers following Industrials-sector stocks, here is Pluang's market snapshot as of Nov 05, 2026 17:21 WIB: out of 135 priced US stocks, 65 rose and 67 fell. Notable movers include Geo Group Inc (GEO) at USD 26.98 with a 1-day change of -2.00%, Comfort Systems USA Inc (FIX) at USD 1,069.96 with a 1-day change of -1.96% and 100% buy order activity, and nVent Electric (NVT) at USD 110.69 with a 1-day change of -1.89% and 95% buy order activity.
On November 4, 2026, Shell plc repurchased a total of 1,876,276 shares across multiple trading venues including LSE, Chi-X, BATS, XAMS, CBOE, and TQEX. The shares were bought at prices ranging from £37.98 to £38.82 and €45.70 to €46.72, with an avera...
Dune has completed a SOC 2 Type II examination with no exceptions, providing institutional clients with verified assurance of its data security standards. This milestone comes as tokenized real-world assets doubled to $32.6 billion and stablecoin mar...
Northern Discovery Metals has finalized the acquisition of a 100% interest in the Cibola copper-gold project in British Columbia from Orogen Royalties. The project covers about 3,567 hectares near Houston, BC, in a region known for porphyry copper de...
Opus Genetics has finished dosing the higher-dose Cohort 2 in its Phase 1/2 trial of OPGx-BEST1, a gene therapy for BEST1-related inherited retinal diseases like Best vitelliform macular dystrophy and autosomal recessive bestrophinopathy. Cohort 2 en...
Perimeter Group Inc. announced a net income of $304.5 million for Q3 2026, reversing a prior year loss of $90.7 million, with net sales up 24% to $389.9 million. Growth was driven by a 14% increase in Fire Safety sales and an 84% surge in Specialty P...
